Suppr超能文献

[膀胱“T1”期浅表肿瘤的监测与预后。88例同质系列病例随访1至22年]

[Surveillance and prognosis of "T1" superficial tumors of the bladder. Homogeneous series of 88 cases followed for 1 to 22 years].

作者信息

Lachand A T, Texier J, Texier P

机构信息

Clinique Sarrette, Compagnie Générale de Santé, 23, rue du Père Corentin, 75014 Paris.

出版信息

Prog Urol. 2001 Jun;11(3):472-7.

Abstract

OBJECTIVE

Define the prognostic factors (risk of recurrence and risk of progression) and the rules for surveillance of stage T1 papillary bladder tumours based on the clinical course of a homogeneous patient series.

MATERIAL AND METHOD

88 T1 bladder tumours recruited from 1975 to 1995 and regularly followed by the same urologist. The follow-up ranged from 1 to 22 years with a mean of 52 months and a median of 48 months.

RESULTS

26% patients relapsed (mean follow-up: 71 months) 74% developed one or more recurrences (mean follow-up: 48 months) with recurrences staged > T1 in 35% of cases. 29/88 patients died from invasive bladder cancer, 14 before 3 years, 19 before 5 years, 28 before 10 years. The risk of recurrence and progression was statistically significantly related to the macroscopic appearance of the tumour; size, number and extent of implantations; its rate of progression assessed by the frequency of recurrence. In patients with no recurrence at 12 months, the risk of recurrence decreased from 74% to 50% and the risk of progression decreased from 35% to 20%. In this cohort, neither histological grading of the initial tumour, nor the degree of invasion of the submucosal lamina propria appeared to modify the prognosis.

CONCLUSION

Stage T1 papillary bladder tumours, generally considered to be a superficial tumours regardless of their histological grade, have a serious prognosis and warrant close endoscopic surveillance during the year following the diagnosis. The subsequent frequency of follow-up can then be adapted to the specific mode of progression of each case, but, regardless of this mode of progression, the authors recommend long-term (life-long?) surveillance.

摘要

目的

基于一组同质患者的临床病程,确定T1期乳头状膀胱肿瘤的预后因素(复发风险和进展风险)以及监测规则。

材料与方法

1975年至1995年间招募的88例T1期膀胱肿瘤患者,由同一位泌尿科医生定期随访。随访时间为1至22年,平均52个月,中位数48个月。

结果

26%的患者复发(平均随访71个月),74%的患者出现一次或多次复发(平均随访48个月),其中35%的病例复发分期>T1。88例患者中有29例死于浸润性膀胱癌,14例在3年内死亡,19例在5年内死亡,28例在10年内死亡。复发和进展风险与肿瘤的宏观表现、种植的大小、数量和范围以及通过复发频率评估的进展速度在统计学上显著相关。在12个月时未复发的患者中,复发风险从74%降至50%,进展风险从35%降至20%。在该队列中,初始肿瘤的组织学分级和黏膜下层固有层的浸润程度似乎均未改变预后。

结论

T1期乳头状膀胱肿瘤,无论其组织学分级如何,通常被认为是浅表肿瘤,但预后严重,在诊断后的一年内需要密切的内镜监测。随后的随访频率可根据每个病例的具体进展模式进行调整,但无论这种进展模式如何,作者建议进行长期(终身?)监测。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验